Organization of Regulatory and Clinical Associates
P.O. Box 3490
Redmond, WA 98073
Current/Future Events - Event View
This is the "Event Detail" view, showing all available information for this event.
If registration is required or recommended, click the 'Register for Webinar' button to start the process.
If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.
Webinar - FDA Presentation: Facility Inspections and Product Recalls (FDA Speakers)
Monday, June 24, 2019, 8:15 AM until 10:00 AM
Webinar - link will be emailed to attendees 2 days prior to the meeting
is required before Sunday, June 23, 2019
Meetings and webinars are scheduled on Pacific Standard Time or Pacific Daylight Time, whichever applies.
Please make sure that the following email address is in your Safe Sender list: email@example.com. System messages like meeting announcements, registration confirmations, webinar login instructions as well as certificates of attendance are sent directly from this email address.
You will receive an email 2 days prior to the meeting date with the webinar login instructions. If you don't receive the instructions within this time frame, please contact us at firstname.lastname@example.org as soon as possible.
PAID FEES ARE NON REFUNDABLE.
For webinar events, payment is REQUIRED at the time of registration.
The link to the webinar is intended for the registered person ONLY and should not be shared.
All attendees MUST be registered.
NOTE: THIS IS A MONDAY MEETING
TOPICS:FDA Presentation: Facility Inspections and Product Recalls, Corrections & Removals(NO recording will be available after the meeting, as per the speakers' request)
Medical Device Inspections - An introduction to how FDA inspections are conducted with an emphasis on medical device inspections.
Product Recalls - 21 CFR 806 explains the medical device recall process. Along with 806, it also covers part 7, and provides links to other guidance documents. It provides a big picture view of the recall process highlighting key elements before, during, and after a correction/removal.
SPEAKERS:Vanessa Y. Jacobs, FDA Supervisory Investigator and Theresa Kirkham, FDA Recall Coordinator
Vanessa Y. Jacobs joined the FDA in 2010 and has experience with food, biologics, and bioresearch monitoring inspections. She is currently supervising a team of medical device and mammography quality Investigators.
Theresa Kirkham is a recall coordinator with the Office of Medical Devices and Radiological Health Operations (OMDRH), Division 3 West. Before joining the FDA, Theresa served as a member of the Security Forces in the United States Air Force in Okinawa and Turkey for four years, with short-term assignments in Kuwait, Korea, and Oman. She attended California State University San Marcos and earned a Bachelor of Science in Biology and a Master of Biotechnology. Over the next several years she worked for a firm that produced antibody-based treatments for cancer. Ms. Kirkham then joined the FDA as a Consumer Safety Officer in the Southwest Import District, at the Otay Mesa Resident Post for three years. After Import Operations, she was selected to support the Generic Drug User Fee Act at the San Diego Resident Post. During her three years as a GDUFA CSO working with the Office of Pharmaceutical Quality Operations (OPQO), Division IV, Ms. Kirkham received both drug and medical device training to conduct inspections of drug/device combination products domestically and internationally. She became an OMDRHO recall coordinator in February 2018.
WHO: Clinical, regulatory, quality, manufacturing and legal